and/or other normal actitivies. The overall result has been encouraging and might justify a more aggressive approach in the management of valvular diseases in this specific group of patients.
Artificial cardiac valves are now widely accepted in the surgical treatment of acquired valvular heart disease in adults. Despite the satisfactory results in adult patients there has been an understandable reluctance to extend the same criteria to the paediatric group. This fear is justifiable, since long-term follow-up studies on the durability and continued competence of valve prostheses are not available.
Despite this disadvantage, in some children whose valves have been damaged to such a degree that medical treatment is no longer effective, heart valve replacement becomes the only possible treatment. Recent (Fig. 1 ). Thirteen were boys and seven girls. The aetiology of the lesions is shown in Table I , the majority being rheumatic. Seventeen patients presented a history of rheumatic fever. Among them the interval between the rheumatic fever and the cardiac symptoms varied from 20 months to 7 years, with an average of 39 months. The functional capacity prior to surgery is plotted in Figure 2 .
Episodes of congestive cardiac failure had occurred or were present at the time of examination in every atient. Left and/or right heart catheterization and angiographic studies were performed in all patients. Six patients underwent aortic valve replacement, 11 mitral, 1 tricuspid, and 2 double valve replacement. Mitral annuloplasty was performed in addition to aortic valve replacement in two patients and tricuspid annuloplasty in addition to mitral valve replacement in another patient.
SURGICAL TECHNIQUE
All the patients were operated upon with the assistance of cardiopulmonary bypass, using the Rigg disposable oxygenator combined with the single head roller pump. A heat exchange unit was incorporated into the arterial line connected to the Zuhdi water pump.
The whole system was primed with Ringer solution and 500 dextrose (1:1). One pint of heparinized blood was used only in patients weighing 15 kg. or less. A hypothermic level of 30°C. was maintained during the bypass period.
Continuous perfusion of both coronary arterites whenever possible was done during aortic valve replacement. Electrically induced ventricular fibrillation was applied in mitral valve replacement to allow uninterrupted myocardial perfusion and prevent the hazard of an air embolus. The surgical technique for valve replacement (prosthesis or graft) has been previously reported (Levy, Vidne, and Lebinshon, 1969) . The type of valve prosthesis used is listed in Table II .
RESULTS
Two patients died in the early post-operative period (1 to 30 days after operation), one of them because of a low output syndrome after an aortic and mitral valve replacement on the third postoperative day. The second had cor bovinum due to mitral, tricuspid, and aortic lesions, and cardiac beats could not be restored at the completion of the procedure. There were two late deaths: the first occurred nine months after tricuspid valve replacement in an 11-year-old girl with Ebstein's anomaly. Although the patient had initially improved following the tricuspid valve replacement, she later developed a leak around the prosthesis with subsequent deterioration. Ten days after a successful repair of the prosthesis insufficiency, the patient developed intractable ventricular tachycardia and fibrillation. The second death occurred in a 16-year-old boy two months after aortic valve replacement by heterograft; he developed subacute endocarditis after discharge from hospital (Table III) .
Post-operative thromboembolism was the main complication after insertion of heart valve prostheses (Vidne and Levy, 1969) . This complication occurred in four patients (2000) , in two after aortic valve replacement and in the other two after mitral valve replacement, between two months and two years after operation. All these patients have recovered completely and are (Bloodwell, Hallman, and Cooley, 1968) . The fact that the patient's functional capacity has been considerably improved, and also that the cardiac sillhouette has significantly decreased in size after operation, indicates that the prosthesis used was of adequate size and probably will not have to be replaced as the patient grows. Of all the patients in this group, perhaps only one with mitral insufficiency due to Marfan's syndrome, who had been operated on at the age of 3 years, might require a second operation later in life (Fig. 6) (Shahin, Eshkol, and .
The indication and choice of operation for mitral insufficiency in children and adolescents is usually the same as for adults, namely, if the valvular deformity does not allow reconstruction, valve replacement becomes mandatory (Levy, Varco, Lillehei, and Edwards, 1963) . In aortic valve disease, however (excluding congenital aortic stenosis), the only treatment is replacement by prosthesis or graft . Of course, a case of small aortic annulus might pose special technical problems and require a specially made prosthesis, which is today available.
The tricuspid valve is rarely affected at this age, and in the majority of cases does not require any attention; however, if a congenital lesion is present, such as Ebstein's anomaly or the A-V communis malformation, the treatment of choice in these circumstances may be valve replacement. In the single case in our group with Ebstein's anomaly, it was our impression that this was done too late (Gueron, Hirsch, Stern, Cohen, and Levy, 1966) .
The question of later valve replacement and the fate of the prostheses currently used is a matter of a longer period of follow-up; at present, however, the overall result has been encouraging and might justify a more aggressive approach toward this specific group of patients to whom many of us were reluctant to offer such definitive treatment as valve replacement. Of interest is the fact that in this period of follow-up no incidence of recurrent rheumatic fever was recorded. All the patients who had a previous history of rheumatic fever were placed under preventive antibiotic therapy.
